Skip to main content
Clinical Trials/NCT05505305
NCT05505305
Completed
Not Applicable

Effects of Time-restricted Eating and Interval Training With Digital Follow-up: A Randomized Controlled Trial

Norwegian University of Science and Technology1 site in 1 country52 target enrollmentSeptember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight and Obesity
Sponsor
Norwegian University of Science and Technology
Enrollment
52
Locations
1
Primary Endpoint
Total fat mass
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will investigate the effects of seven weeks of time-restricted eating combined with high-intensity interval training compared with a control group on body composition in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive weekly follow-up through online platforms (telephone, video call). Before and after the intervention, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
May 13, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Body mass index ≥ 27 kg/m²
  • Able to walk or ride a bike \> 60 min

Exclusion Criteria

  • On-going pregnancy
  • Lactation within 24 weeks of study commencement
  • High-intensity exercise ≥ 1/week
  • Habitual eating window ≤12 hours/day
  • Taking hypertension, glucose-, or lipid-lowering drugs
  • Body mass variation ≥ 4 kg three months prior to study commencement
  • Known diabetes mellitus (type 1 or 2) or cardiovascular disease
  • Working night shifts

Outcomes

Primary Outcomes

Total fat mass

Time Frame: From baseline to after 7 weeks of intervention

Change in total fat mass measured with bioelectrical impedance analysis

Secondary Outcomes

  • Insulin(From baseline to after 7 weeks of intervention)
  • Systolic blood pressure(From baseline to after 7 weeks of intervention)
  • Physical activity level(From baseline to after 7 weeks of intervention)
  • Average glucose levels(From baseline to after 7 weeks of intervention)
  • Blood Cholesterol(From baseline to after 7 weeks of intervention)
  • Cardiorespiratory fitness(From baseline to after 7 weeks of intervention)
  • Visceral fat area(From baseline to after 7 weeks of intervention)
  • Sleep duration(7 days at baseline, 7 days at start of intervention, 7 days at end of intervention)
  • Blood glucose(From baseline to after 7 weeks of intervention)
  • Insulin sensitivity(From baseline to after 7 weeks of intervention)
  • HDL-cholesterol in blood(From baseline to after 7 weeks of intervention)
  • Triglycerides in blood(From baseline to after 7 weeks of intervention)
  • Body mass(From baseline to after 7 weeks of intervention)
  • LDL-cholesterol in blood(From baseline to after 7 weeks of intervention)
  • Body fat-free mass(From baseline to after 7 weeks of intervention)
  • Diastolic blood pressure(From baseline to after 7 weeks of intervention)
  • Resting heart rate(From baseline to after 7 weeks of intervention)
  • Appetite(7 days at baseline, 7 days at start of intervention, 7 days at end of intervention)
  • Sleep quality(From baseline to after 7 weeks of intervention)
  • Self-reported physical activity(7 days at baseline, 7 days at start of intervention, 7 days at end of intervention.)
  • Diet intake(7 days at baseline, 7 days at start of intervention, 7 days at end of intervention.)

Study Sites (1)

Loading locations...

Similar Trials